KLF2 and Other metabolic disease: Peripheral K2KO myeloid cells also contribute to dysregulated glucose homeostasis as evidenced by IPGTT and IPITT (Fig. 5d, e), further underscoring a substantial role for peripheral loss of myeloid KLF2 in metabolic disease.